•
Sep 30, 2016

CRISPR Therapeutics Q3 2016 Earnings Report

Total Revenue
$1.55M
EPS
-$2.77
Previous year: -$0.217
+1177.2%
Gross Profit
-$10.5M
Previous year: -$3.75M
+180.2%
Cash and Equivalents
$229M
Total Assets
$279M

CRISPR Therapeutics

CRISPR Therapeutics